HomeQuestion

Is anifrolumab safe to use in patients with a history of malignancy?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

In a patient with strong serologic evidence of SLE presenting with isolated bilateral lower limb sensorimotor neuropathy, normal neuroimaging, and CSF, would you initiate cyclophosphamide with pulse-dose steroids upfront, or reserve escalation (e.g., plasma exchange or immunosuppressants) for cases refractory to steroids?

How would you approach a patient with newly diagnosed lupus/lupus nephritis receiving cyclophosphamide (euro lupus protocol) with active hemolysis not responding to steroids or IVIG?

Are there patients with SLE associated inflammatory arthritis in whom you recommend TNF inhibitors as a treatment option?

What maintenance regimen do you use for a patient with lupus cerebritis?

How do you manage a patient with SLE with acute bilateral sensorineural hearing loss refractory to high dose systemic and intratympanic steroids, normal MRI brain and APL labs?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.

Is anifrolumab safe to use in patients with a history of malignancy? | Mednet